Phase I Study of Vorinostat in Combination with Decitabine in Patients with Relapsed or Newly Diagnosed Acute Myelogenous Leukemia or Myelodysplastic Syndrome

被引：0
|
作者：
Kirschbaum, Mark [1 ]
Gojo, Ivana [2 ]
Goldberg, Stuart L. [3 ]
Kujawski, Lisa [4 ]
Atallah, Ehab [5 ]
Marks, Peter [6 ]
Garcia-Vargas, Jose [7 ]
Rizvi, Syed [7 ]
Di Gravio, Donna [7 ]
Ahern, Janet [7 ]
Issa, Jean-Pierre [8 ]
机构：
[1] City Hope Natl Med Ctr, Duarte, CA 91010 USA
[2] Univ Maryland, Med Ctr, Baltimore, MD 21201 USA
[3] Hackensack Univ, Med Ctr, John Theurer Canc Ctr, Hackensack, NJ USA
[4] Univ Michigan, Ann Arbor, MI 48109 USA
[5] Med Coll Wisconsin, Milwaukee, WI 53226 USA
[6] Yale Univ, Sch Med, New Haven, CT USA
[7] Merck & Co Inc, Upper Gwynedd, PA USA
[8] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1250 / 1250
页数：1
相关论文
共 50 条
  • [31] Pain in patients with newly diagnosed or relapsed acute leukemia
    Shaulov, Adir
    Rodin, Gary
    Popovic, Gordana
    Caraiscos, Valerie B.
    Le, Lisa W.
    Rydall, Anne
    Schimmer, Aaron D.
    Zimmermann, Camilla
    SUPPORTIVE CARE IN CANCER, 2019, 27 (08) : 2789 - 2797
  • [32] Pain in patients with newly diagnosed or relapsed acute leukemia
    Adir Shaulov
    Gary Rodin
    Gordana Popovic
    Valerie B. Caraiscos
    Lisa W. Le
    Anne Rydall
    Aaron D. Schimmer
    Camilla Zimmermann
    Supportive Care in Cancer, 2019, 27 : 2789 - 2797
  • [33] Decitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia and High-Risk Myelodysplastic Syndrome
    Borthakur, Gautam
    Estrov, Zeev
    Garcia-Manero, Guillermo
    Williams, Betsy
    Wathen, Jay K.
    Konopleva, Marina
    Burger, Jan
    Ferrajoli, Alessandra
    George, Solly
    Kantarjian, Hagop
    BLOOD, 2008, 112 (11) : 1026 - 1026
  • [34] Phase I Trial of Belinostat and Bortezomib in Patients with Relapsed or Refractory Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia in Blast Crisis - One Year Update
    Holkova, Beata
    Bose, Prithviraj
    Tombes, Mary Beth
    Shrader, Ellen
    Wan, Wen
    Weir-Wiggins, Caryn
    Stoddert, Elizabeth
    Sankala, Heidi
    Kmieciak, Maciej
    Roberts, John D.
    Garcia-Manero, Guillermo
    Grant, Steven
    BLOOD, 2012, 120 (21)
  • [35] Phase I study of pemetrexed in patients with relapsed or refractory acute leukemia or lymphoid blast phase chronic myelogenous leukemia
    Plunkett, W.
    Thomas, D. A.
    O'Brien, S. M.
    Federl, S.
    Giles, F. J.
    Nicol, S. J.
    Gill, J.
    Zhao, L.
    Ravandi, F.
    Kantarjian, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [36] Phase II study of decitabine and gemtuzumab ozogamicin (GO) in acute myelogenous leukemia (AML) and high-risk myelodysplastic syndrome (MDS).
    Chen, Y.
    Kantarjian, H.
    Garcia-Manero, G.
    Estrov, Z.
    Konopleva, M.
    Jabbour, E.
    Kadia, T. M.
    Williams, E.
    George, S.
    Borthakur, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [37] A phase I study of idarubicin dose escalation with amifostine and high-dose cytarabine in patients with relapsed acute myelogenous leukemia and myelodysplastic syndromes
    Garcia-Manero, G
    Faderl, S
    Giles, F
    Thomas, D
    Cortes, J
    O'Brien, S
    Davis, J
    Kantarjian, HM
    Estey, E
    HAEMATOLOGICA, 2002, 87 (08) : 804 - 807
  • [38] Final Report of a Phase II Study of 5-Azacitidine and Vorinostat in Patients (pts) with Newly Diagnosed Myelodysplastic Syndrome (MDS) or Acute Myelogenous Leukemia (AML) Not Eligible for Clinical Trials Because Poor Performance and Presence of Other Comorbidities
    Garcia-Manero, Guillermo
    Estey, Elihu H.
    Jabbour, Elias
    Borthakur, Gautam
    Kadia, Tapan
    Naqvi, Kiran
    Levine, Ross L.
    Estrov, Zeev
    Quintas-Cardama, Alfonso
    Konopleva, Marina
    Faderl, Stefan
    Tanaka, Maria
    Yang, Hui
    Ravandi, Farhad
    Wierda, William G.
    Cortes, Jorge E.
    Boone, Patricia Ann
    Kantarjian, Hagop M.
    BLOOD, 2011, 118 (21) : 279 - 279
  • [39] Phase I study of vorinostat in combination with standard CHOP in patients with newly diagnosed peripheral T-cell lymphoma
    Oki, Yasuhiro
    Younes, Anas
    Copeland, Amanda
    Hagemeister, Fredrick
    Fayad, Luis E.
    McLaughlin, Peter
    Shah, Jatin
    Fowler, Nathan
    Romaguera, Jorge
    Kwak, Larry W.
    Pro, Barbara
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 162 (01) : 138 - 141
  • [40] A Phase I Study of Pevonedistat, Azacitidine and Venetoclax for Patients with Relapsed/Refractory Acute Myelogenous Leukemia (AML)
    Murthy, Guru Subramanian Guru
    Kaufmann, Scott H.
    Szabo, Aniko
    Harrington, Alexandra M.
    Michaelis, Laura C.
    Abedin, Sameem
    Carlson, Karen
    Runaas, Lyndsey
    Longo, Walter L.
    Hinman, Alexander
    Maldonado-Schmidt, Sonia
    Thomas, Althea
    Baim, Arielle
    Litzow, Mark R.
    Atallah, Ehab L.
    BLOOD, 2021, 138
12345